1. Sensitivity and specificity of a rapid point-of-care test for active yaws: a comparative study 
Telek Ayove, BSc, Wendy Houniei, HEO, Regina Wangnapi, MBBS, Sibauk V Bieb, MBBS, Walter Kazadi, MD, Lisol-Nirau Luke, BSc, Clement Manineng, MBBS, Penias Moses, HEO, Raymond Paru, BSc, Javan Esfandiari, MSc, Prof Pedro L Alonso, MD, Elisa de Lazzari, MSc, Quique Bassat, MD, Prof David Mabey, MD, Dr Oriol Mitjà, MD 
The Lancet Global Health 
Volume 2, Issue 7, Pages e415-e421 (July 2014)
DOI: /S X(14)
Copyright © 2014 Ayove et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2. Figure 1 Recruitment and testing algorithm
DPP=Dual Path Platform assay. RPR=rapid plasma reagin test. TPHA=Treponema pallidum haemagglutination assay.
The Lancet Global Health 2014 2, e415-e421DOI: ( /S X(14) )
Copyright © 2014 Ayove et al. Open Access article distributed under the terms of CC BY Terms and Conditions

3. Figure 2 Seropositivity pattern of quantitative tests
DPP T2=Dual Path Platform T2 (non-treponemal) assay. RPR=rapid plasma reagin test.
The Lancet Global Health 2014 2, e415-e421DOI: ( /S X(14) )
Copyright © 2014 Ayove et al. Open Access article distributed under the terms of CC BY Terms and Conditions

4. Figure 3 Optical density of DPP assay during the study
Optical density was measured by an automated reader. Red dots indicate mean values and error bars represent 95% CIs. (Upper panel) DPP T1 (treponemal) assay. (Lower panel) DPP T2 (non-treponemal) assay. DPP=Dual Path Platform.
The Lancet Global Health 2014 2, e415-e421DOI: ( /S X(14) )
Copyright © 2014 Ayove et al. Open Access article distributed under the terms of CC BY Terms and Conditions